We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phase I Clinical Trials of Cancer Drug ETS2101 Approved by Regulators

News   Mar 29, 2012

 
Phase I Clinical Trials of Cancer Drug ETS2101 Approved by Regulators
 
 
 

RELATED ARTICLES

A Potential New Treatment for Preventing PTSD

News

A team of researchers has identified a protein complex that is elevated in patients with post-traumatic stress disorder (PTSD). The team have designed a peptide to target and interfere with the complex, this interference could help treat symptoms of the disorder.

READ MORE

Gene Therapy for Life-limiting Blood Disorder Becomes Commercially Available

News

bluebird bio Inc. have announced that their gene therapy for the blood disorder transfusion-dependent β-thalassemia (TDT) is commercially available for the first time.

READ MORE

Diabetes Drug May Help To Prevent Miscarriage

News

According to a new study, an existing drug could be used to improve the womb for pregnancy in those who have had recurrent miscarriages.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE